Workflow
股份回购注销
icon
Search documents
中南文化: 关于控股股东及其一致行动人持股比例因公司注销回购股份被动增加至 30%以上暨免于要约收购的提示性公告
Zheng Quan Zhi Xing· 2025-06-30 16:11
Core Viewpoint - The company, Zhongnan Culture Group Co., Ltd., has completed a share buyback program, resulting in a change in the shareholding structure of its controlling shareholder, which has increased its holding to over 30% and is exempt from making a tender offer [1][2]. Summary by Sections Share Buyback Details - The company approved a share buyback plan on July 10, 2024, with a total fund of no less than RMB 30 million and no more than RMB 60 million, at a maximum price of RMB 2.66 per share, to be executed within 12 months [1]. - The maximum buyback price was later adjusted to RMB 3.6 per share on January 2, 2025 [1]. - The total number of shares repurchased was 15,060,800, representing 0.63% of the total share capital before cancellation, with a total expenditure of RMB 30.54 million [2]. Changes in Shareholding Structure - Following the completion of the share buyback and cancellation, the total number of shares decreased from 2,391,668,331 to 2,376,607,531 [4]. - The controlling shareholder, Chengbang Enterprise Management, and its concerted party, Jiangyin Xinguolian Electric Power Development Co., Ltd., maintained their total shareholding at 716,798,390 shares, increasing their ownership percentage from 29.97% to 30.16% [4]. Other Matters - The change in shareholding does not result in a substantial change in the company's control structure, and it will not adversely affect corporate governance or the interests of minority shareholders [4]. - The company is exempt from making a tender offer due to the nature of the shareholding change as per relevant regulations [4].
中南文化: 关于回购股份注销完成暨股份变动的公告
Zheng Quan Zhi Xing· 2025-06-30 16:11
Core Viewpoint - The company has completed a share buyback program, reducing its registered capital and total share count, while adjusting the maximum buyback price. Group 1: Share Buyback Announcement - The company approved a share buyback plan with a total fund of no less than RMB 30 million and no more than RMB 60 million, with a maximum price of RMB 2.66 per share [2] - The company adjusted the maximum buyback price to RMB 3.6 per share while keeping other terms unchanged [3] Group 2: Implementation and Completion of Buyback - The company repurchased 690,000 shares at a total cost of RMB 1.1247 million, with a maximum and minimum transaction price of RMB 1.63 per share [3] - A total of 15,060,800 shares were repurchased, representing 0.63% of the total share capital before the buyback, with a total transaction amount of RMB 30.5415 million [4] - The company completed the cancellation of the repurchased shares on June 27, 2025, reducing the total share capital from 2,391,668,331 shares to 2,376,607,531 shares [5] Group 3: Impact and Structural Changes - The buyback will not significantly impact the company's operations, profitability, or financial status, nor will it change the control of the company [5] - The share structure post-buyback shows that the number of unrestricted circulating shares decreased by 15,060,800 shares, while the total share capital was adjusted accordingly [5]
国科军工: 关于实施回购股份注销暨股份变动的公告
Zheng Quan Zhi Xing· 2025-06-27 16:12
Core Points - Jiangxi Guoke Military Industry Group Co., Ltd. plans to cancel 1,666,533 shares from its repurchase special securities account, reducing the total share capital from 210,508,561 shares to 208,842,028 shares after the cancellation [1][5][7] Summary by Sections Repurchase and Cancellation Details - The company approved the adjustment of the purpose of the repurchased shares from "for employee stock ownership plans" to "for cancellation and reduction of registered capital" during meetings held on March 24, 2025, April 16, 2025, and the 2024 annual shareholders' meeting [2][3] - The repurchase was completed on February 7, 2025, with a total of 1,666,533 shares acquired, representing 0.9485% of the total share capital, at a total cost of approximately RMB 76.13 million [3][4] Approval Process - The company followed the necessary legal procedures for the cancellation of the repurchased shares, including notifying creditors, with no objections received during the creditor notification period [4][7] Impact on Share Capital Structure - Following the cancellation, the share capital structure will change, with the number of limited and unrestricted shares adjusted accordingly, maintaining compliance with listing requirements [5][6][7] - The total share capital will decrease from 210,508,561 shares to 208,842,028 shares, with specific changes in the proportions of limited and unrestricted shares [6][7] Future Arrangements - The cancellation is expected to enhance earnings per share and improve shareholder returns without significantly impacting the company's financial status or operational capabilities [7]
九洲药业: 浙江九洲药业股份有限公司关于注销部分已回购股份的实施公告
Zheng Quan Zhi Xing· 2025-06-25 17:34
Core Viewpoint - Zhejiang Jiuzhou Pharmaceutical Co., Ltd. has decided to change the purpose of its share repurchase plan from "for future implementation of equity incentive plans" to "for cancellation and reduction of registered capital" by canceling 5,789,800 shares from its repurchased stock account [1][3]. Group 1: Share Repurchase Plan - The company proposed a share repurchase plan on December 26, 2023, to buy back shares using its own funds through centralized bidding, initially intended for equity incentive or employee stock ownership plans [1]. - On January 4, 2024, the board approved the repurchase plan, allowing the company to buy back shares at a price not exceeding RMB 36 per share, with a total repurchase amount between RMB 50 million and RMB 100 million within 12 months [2]. - The actual repurchase was completed, with a total of 5,789,800 shares bought back, accounting for 0.65% of the company's total share capital, with a total expenditure of approximately RMB 99.89 million [2][3]. Group 2: Share Cancellation Details - The company plans to cancel the repurchased shares and reduce its registered capital accordingly, with the cancellation process having been approved in board meetings held on April 10 and May 8, 2025 [3]. - The cancellation of 5,789,800 shares will reduce the total share capital from 895,235,828 shares to 889,446,028 shares, maintaining the same percentage of unlimited sale shares at 100% [5]. - The company has completed the necessary creditor notification procedures, and no claims or guarantees were requested by creditors during the public notice period [3].
天润乳业: 新疆天润乳业股份有限公司关于注销回购股份减少注册资本通知债权人的公告
Zheng Quan Zhi Xing· 2025-06-24 19:18
Group 1 - The company has approved a share repurchase plan to buy back between 3,200,000 and 4,800,000 shares at a price not exceeding RMB 15.00 per share, using its own funds for employee stock ownership plans or equity incentives [2][3] - The company will change the purpose of the repurchased shares from employee stock ownership plans to cancellation and reduction of registered capital, following the approval at the 2025 first extraordinary general meeting [2][3] - After the cancellation of the repurchased shares, the total share capital will decrease from 320,203,603 shares to 315,403,648 shares, and the registered capital will reduce from RMB 320,203,603 to RMB 315,403,648 [3] Group 2 - Creditors have the right to request debt repayment or guarantees within 30 days of receiving the notice, or within 45 days from the announcement date if they have not received a notice [3][4] - The company has outlined the necessary documentation for creditors to declare their claims, including contracts and identification documents [4]
奋达科技: 简式权益变动报告书
Zheng Quan Zhi Xing· 2025-06-23 11:54
深圳市奋达科技股份有限公司 上市公司名称:深圳市奋达科技股份有限公司 股票上市地点:深圳证券交易所 股票简称:奋达科技 股票代码:002681 信息披露义务人一:肖奋 住所:深圳市宝安区宝城上川路 通讯地址:深圳市宝安区石岩街道洲石路奋达科技园 信息披露义务人二:刘方觉 住所:深圳市宝安区宝城上川路 通讯地址:深圳市宝安区石岩街道洲石路奋达科技园 信息披露义务人三:肖韵 住所:深圳市宝安区宝城上川路 通讯地址:深圳市宝安区石岩街道洲石路奋达科技园 信息披露义务人四:肖勇 住所:深圳市宝安区宝城上川路 通讯地址:深圳市宝安区石岩街道洲石路奋达科技园 信息披露义务人五:肖武 住所:深圳市宝安区宝城甲岸路 通讯地址:深圳市宝安区石岩街道洲石路奋达科技园 信息披露义务人六:肖文英 住所:深圳市宝安区宝城甲岸路 通讯地址:深圳市宝安区石岩街道洲石路奋达科技园 信息披露义务人七:肖晓 住所:深圳市宝安区石岩街道洲石路 通讯地址:深圳市宝安区石岩街道洲石路奋达科技园 信息披露义务人声明 一、信息披露义务人依据《中华人民共和国证券法》(以下简称"《证券 法》")、《上市公司收购管理办法》(以下简称"《收购管理办法》")、《公 ...
普洛药业: 关于回购股份注销完成暨股份变动的公告
Zheng Quan Zhi Xing· 2025-06-22 08:40
Core Viewpoint - The company has completed the cancellation of repurchased shares, reducing its total share capital from 1,169,323,576 shares to 1,158,443,576 shares, which is expected to enhance earnings per share and improve shareholder returns [1][2][3] Summary by Sections 1. Approval and Implementation of Share Repurchase - The company approved a share repurchase plan on March 27, 2024, allowing for the repurchase of shares at a price not exceeding RMB 20 per share, with a total repurchase fund of at least RMB 153 million [1][2] - The actual repurchase involved 10,880,000 shares, accounting for 0.93% of the total share capital, with a total transaction amount of approximately RMB 153 million [1][2] 2. Cancellation of Repurchased Shares - The cancellation of the repurchased shares was confirmed by the China Securities Depository and Clearing Corporation on June 19, 2025, in compliance with relevant laws and regulations [2][3] - The number of shares canceled was 10,880,000, which represented 0.93% of the total share capital before cancellation [2] 3. Changes in Shareholding Structure - Following the cancellation, the total number of shares decreased to 1,158,443,576, with the structure remaining compliant with listing requirements [2][3] - The proportion of unrestricted circulating shares slightly decreased from 99.9628% to 99.9624% after the cancellation [2] 4. Impact of Share Cancellation - The cancellation is expected to enhance the company's earnings per share and improve returns for shareholders without significantly affecting the company's financial status or future development [3] - The cancellation will not harm the interests of shareholders, particularly minority shareholders, and will not lead to changes in the controlling shareholder or actual controller [3] 5. Follow-up Arrangements - The company will proceed with necessary changes in business registration and articles of association as per legal requirements following the completion of the share cancellation [3]
ST华通: 关于定向回购注销业绩补偿股份减资暨通知债权人的公告
Zheng Quan Zhi Xing· 2025-06-19 12:57
Core Points - Zhejiang Century Huatong Group Co., Ltd. has announced a plan for a directed buyback and cancellation of performance compensation shares, which was approved in meetings held on May 30, 2025, and June 19, 2025 [1][2] - The company will repurchase a total of 126,627,700 shares at a total price of RMB 1.00, which represents a significant portion of the company's total share capital prior to the buyback [2] - The buyback will lead to a reduction in the company's registered capital, and creditors have a 30-day period from notification to claim their debts or request guarantees [2][3] Company Information - The company will apply to the China Securities Depository and Clearing Co., Ltd. for the cancellation of the performance compensation shares and will fulfill its information disclosure obligations after the implementation is completed [4] - Creditors must provide valid documentation to assert their claims, and the submission period for claims is from June 20, 2025, to August 3, 2025 [3][4]
大丰实业: 浙江大丰实业股份有限公司关于调整2024年度利润分配现金分红总额的公告
Zheng Quan Zhi Xing· 2025-06-19 10:21
Core Viewpoint - The company has adjusted the total cash dividend for the 2024 profit distribution due to a change in total share capital resulting from the repurchase and cancellation of restricted stock options Summary by Sections Announcement of Adjustment - The company maintains a cash dividend of 1.3 RMB per 10 shares (including tax), with the total cash dividend amount adjusted from 55,332,127.37 RMB (including tax) to 54,924,889.37 RMB (including tax) [1] Reason for Adjustment - The adjustment is due to the repurchase and cancellation of 3,132,600 shares of restricted stock, which altered the company's total share capital [1][2] Original Profit Distribution Plan - The original profit distribution plan proposed a cash dividend of 0.13 RMB per share, totaling 55,332,127.37 RMB (including tax) based on the total share capital as of March 2025 [1][3] - The total amount for cash dividends and share repurchases was 125,155,668.33 RMB, representing 193.71% of the net profit attributable to shareholders [1] Adjusted Profit Distribution Plan - Following the adjustment, the company will distribute a cash dividend of 1.3 RMB per 10 shares, leading to a total cash dividend of 54,924,889.37 RMB (including tax) based on the adjusted total share capital of 433,392,868 shares [3][4] - The adjusted cash dividend and repurchase amount represent 85.01% of the net profit attributable to shareholders [4]
中化装备: 中化装备科技(青岛)股份有限公司关于回购并注销股份暨减少注册资本通知债权人的公告
Zheng Quan Zhi Xing· 2025-06-19 08:30
Core Viewpoint - The company plans to execute a share buyback as a substitute for dividend distribution, with a maximum buyback price of 12.37 RMB per share, totaling an estimated buyback amount of 9.8352 million RMB, which will reduce the total share capital by 0.16% [1][3]. Group 1: Share Buyback Details - The company intends to repurchase no less than 795,089 shares, which represents 0.16% of the total share capital [1]. - Following the completion of the buyback and cancellation, the total share capital is expected to decrease from 494,712,359 shares [1]. Group 2: Creditor Notification - Creditors have the right to request debt repayment or corresponding guarantees within 30 days of receiving the notice, or within 45 days from the announcement date if no notice is received [1]. - The company assures that creditors' rights will remain valid even if they do not act within the specified timeframe, and obligations will continue as per the original debt agreements [1]. Group 3: Debt Claim Submission - Specific materials required for debt claim submission include business licenses and identification documents for legal entities and individuals, respectively [2]. - The claim submission period is from June 20, 2025, to August 4, 2025, with designated contact information provided for inquiries [2].